[PDF][PDF] Long-Term Results of a Randomized Trial on Extended Use of High Dose l-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia
A Pession, MG Valsecchi, G Masera… - Journal of clinical …, 2005 - researchgate.net
A Pession, MG Valsecchi, G Masera, WA Kamps, E Magyarosy, C Rizzari, ER Van Wering…
Journal of clinical oncology, 2005•researchgate.netPurpose Between September 1991 and May 1997, within the International Berlin-Frankfurt-
Muenster Study Group (I-BFM-SG), a randomized study was performed aimed at assessing
the efficacy of prolonged use of high-dose L-asparaginase (HD-L-ASP) during continuation
therapy in children with standard risk (SR) acute lymphoblastic leukemia (ALL), treated with
a reduced BFM-type chemotherapy.
Muenster Study Group (I-BFM-SG), a randomized study was performed aimed at assessing
the efficacy of prolonged use of high-dose L-asparaginase (HD-L-ASP) during continuation
therapy in children with standard risk (SR) acute lymphoblastic leukemia (ALL), treated with
a reduced BFM-type chemotherapy.
Purpose
Between September 1991 and May 1997, within the International Berlin-Frankfurt-Muenster Study Group (I-BFM-SG), a randomized study was performed aimed at assessing the efficacy of prolonged use of high-dose L-asparaginase (HD-L-ASP) during continuation therapy in children with standard risk (SR) acute lymphoblastic leukemia (ALL), treated with a reduced BFM-type chemotherapy.
researchgate.net